Form 8-K - Current report:
SEC Accession No. 0001387131-20-008104
Filing Date
2020-08-31
Accepted
2020-08-31 17:02:17
Documents
6
Period of Report
2020-08-31
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_083120.htm 8-K 25181
2 CERTIFICATE OF AMENDMENT TO TONIX PHARMACEUTICALS HOLDING CORP.'S ARTICLES OF IN ex3-01.htm EX-3.01 3336
3 GRAPHIC ex301-01.gif GRAPHIC 78272
4 GRAPHIC ex301-02.gif GRAPHIC 180707
5 GRAPHIC ex301-03.gif GRAPHIC 151971
6 GRAPHIC ex301-04.gif GRAPHIC 61119
  Complete submission text file 0001387131-20-008104.txt   680091
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

EIN.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 201152225
SIC: 2834 Pharmaceutical Preparations